Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
101.06
+9.51 (10.39%)
At close: Aug 3, 2026, 4:00 PM EDT
101.00
-0.06 (-0.06%)
After-hours: Aug 3, 2026, 7:43 PM EDT
Twist Bioscience Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Cash & Equivalents | 117.44 | 183.05 | 226.32 | 286.47 | 378.69 | 465.83 |
Short-Term Investments | 49.4 | 49.39 | 50.08 | 49.94 | 126.28 | 12.03 |
Cash & Short-Term Investments | 166.84 | 232.43 | 276.4 | 336.41 | 504.97 | 477.86 |
Cash Growth | -33.48% | -15.91% | -17.84% | -33.38% | 5.67% | 64.78% |
Accounts Receivable | 65.06 | 57.02 | 34.9 | 44.06 | 40.29 | 28.55 |
Inventory | 35.16 | 28.31 | 24.08 | 32.06 | 39.31 | 31.8 |
Other Current Assets | 54.24 | 15.2 | 11.4 | 11.72 | 11.91 | 8.28 |
Total Current Assets | 321.3 | 332.97 | 346.78 | 424.26 | 596.48 | 546.5 |
Net Property, Plant & Equipment | 180.62 | 151.66 | 161.35 | 203.36 | 214.39 | 105.7 |
Other Intangible Assets | 12.73 | 13.43 | 14.48 | 54.48 | 59.74 | 18.26 |
Goodwill | 82.2 | 82.19 | 85.81 | 85.81 | 85.81 | 22.43 |
Long-Term Investments | 68.09 | 54.34 | 1.53 | - | - | - |
Other Long-Term Assets | 7.51 | 7.28 | 4.38 | 8.49 | 4.96 | 9.2 |
Total Assets | 672.44 | 641.86 | 614.32 | 776.4 | 961.38 | 702.1 |
Accounts Payable | 17.04 | 11.09 | 1.63 | 14.05 | 20.09 | 14.9 |
Accrued Expenses | 34.88 | 54.34 | 48.75 | 36.57 | 37.19 | 28.76 |
Current Portion of Long-Term Debt | - | - | - | - | - | 1.55 |
Current Portion of Leases | 8.63 | 13.82 | 14.81 | 14.9 | 13.64 | 8.21 |
Other Current Liabilities | 59.7 | 12.15 | 5.82 | 7.8 | 19.74 | 9.62 |
Total Current Liabilities | 120.26 | 91.41 | 71.01 | 73.32 | 90.66 | 63.05 |
Long-Term Leases | 84.96 | 42.75 | 70.22 | 79.17 | 81.27 | 53.16 |
Other Long-Term Liabilities | 21.48 | 34.75 | 0.41 | 0.48 | 0.06 | 5.07 |
Total Long-Term Liabilities | 106.44 | 77.5 | 70.63 | 79.65 | 81.33 | 58.22 |
Total Liabilities | 226.7 | 168.9 | 141.63 | 152.97 | 171.99 | 121.28 |
Additional Paid-in Capital | 1,876 | 1,793 | 1,715 | 1,657 | 1,620 | 1,191 |
Accumulated Other Comprehensive Income | -0.66 | -0.63 | -0.62 | -0.76 | -1.84 | 0.55 |
Retained Earnings | -1,429 | -1,320 | -1,242 | -1,033 | -828.42 | -610.55 |
Shareholders' Equity | 445.74 | 472.96 | 472.69 | 623.43 | 789.39 | 580.82 |
Total Liabilities & Equity | 672.44 | 641.86 | 614.32 | 776.4 | 961.38 | 702.1 |
Total Debt | 93.59 | 56.57 | 85.03 | 94.07 | 94.91 | 62.92 |
Net Cash (Debt) | 73.25 | 175.86 | 191.37 | 242.34 | 410.06 | 414.94 |
Net Cash Growth | -57.57% | -8.11% | -21.03% | -40.90% | -1.18% | 63.35% |
Net Cash Per Share | 1.19 | 2.94 | 3.30 | 4.26 | 7.61 | 8.60 |
Book Value | 445.74 | 472.96 | 472.69 | 623.43 | 789.39 | 580.82 |
Book Value Per Share | 7.26 | 7.91 | 8.15 | 10.96 | 14.65 | 12.04 |
Tangible Book Value | 350.81 | 377.34 | 372.4 | 483.14 | 643.84 | 540.13 |
Tangible Book Value Per Share | 5.71 | 6.31 | 6.42 | 8.49 | 11.95 | 11.19 |